Metraipolis › archive › dc_02c588e7cc10

Pharmacovigilance of Androgen Receptor Pathway Inhibitors in Prostate Cancer: The Impact of Docetaxel Co-Reporting — Europe PMC PMID:42795015

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42795015
DOI
10.3390/cancers18183049
License (as archived)
solo-consultazione
Archived
2026-10-08T02:28:36.533Z
SHA-256 of the archived text
1ebc94ba770b09239bdbf8b56b38b649f7d290b8f046679916c26489223d5a38
Stable URL of this page
https://metraipolis.com/documento/dc_02c588e7cc10

How to cite

Pharmacovigilance of Androgen Receptor Pathway Inhibitors in Prostate Cancer: The Impact of Docetaxel Co-Reporting — Europe PMC PMID:42795015 — Europe PMC (en), https://europepmc.org/article/MED/42795015 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_02c588e7cc10 (Metraipolis archive dc_02c588e7cc10, sha256 1ebc94ba770b09239bdbf8b56b38b649f7d290b8f046679916c26489223d5a38)
BibTeX
@misc{dc02c588e7cc10,
  title = {Pharmacovigilance of Androgen Receptor Pathway Inhibitors in Prostate Cancer: The Impact of Docetaxel Co-Reporting — Europe PMC PMID:42795015},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42795015},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_02c588e7cc10; sha256 1ebc94ba770b09239bdbf8b56b38b649f7d290b8f046679916c26489223d5a38},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42795015. Agents can read the archived copy with the MCP tool read_document.